ORGO EBITDA | ORGANOGENESIS HOLDINGS INC.

ORGANOGENESIS HOLDINGS INC. (ORGO) EBITDA

2026-06-30: Basis Reported; EBITDA -$47.32M*; Operating income -$50.99M; Depreciation and amortization $3.67M*.
2026-03-31: Basis Reported; EBITDA -$64.72M; Operating income (m); Depreciation and amortization (m).
2025-12-31: Basis Reported; EBITDA $67.36M; Operating income (m); Depreciation and amortization (m).
2025-09-30: Basis Reported; EBITDA $24.76M*; Operating income $20.73M; Depreciation and amortization $4.03M*.

Complete source-backed ebitda history.

Available history: 2022-12-31 to 2026-03-31
Data captured: 2026-09-04

Historical EBITDA

EBITDA 3 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2026-06-30	Reported	-$47.32M*	-$50.99M	$3.67M*	(m)	(m)	$1.10M*	-$31.65M*	(m)	$18.30M	$53.97M	$45.39M
2026-03-31	Reported	-$64.72M	(m)	(m)	(m)	-173.84%	$3.15M	$21.13M	(m)	$15.16M	$65.19M	-$15.32M
2025-12-31	Reported	$67.36M	(m)	(m)	(m)	29.86%	(m)	(m)	(m)	(m)	(m)	(m)
2025-09-30	Reported	$24.76M*	$20.73M	$4.03M*	(m)	(m)	$2.23M*	$3.08M*	(m)	$13.22M	$79.74M	-$407.00K
2025-06-30	Reported	-$8.84M*	-$12.58M	$3.73M*	(m)	(m)	$3.64M*	-$32.87M*	(m)	$10.39M	$73.81M	-$2.44M
2025-03-31	Reported	-$23.3M	(m)	(m)	(m)	-26.88%	$3.63M	-$19.93M	(m)	$10.64M	$72.51M	-$6.94M
2024-12-31	Reported	$13.83M	(m)	(m)	(m)	10.92%	(m)	(m)	(m)	(m)	(m)	(m)
2024-09-30	Reported	$9.81M	(m)	(m)	(m)	8.52%	$2.57M*	$8.70M*	(m)	$10.34M	$71.80M	-$6.51M
2024-06-30	Reported	-$10.53M	(m)	(m)	(m)	-8.08%	$1.88M*	$4.74M*	(m)	$15.59M	$76.54M	$2.50M
2024-03-31	Reported	-$780,000.00	(m)	(m)	(m)	-0.71%	$2.22M	-$10.16M	(m)	$12.81M	$72.32M	-$2.24M
2023-12-31	Reported	$1.71M	(m)	(m)	(m)	1.72%	(m)	(m)	(m)	(m)	(m)	(m)
2023-09-30	Reported	$10.59M	(m)	(m)	(m)	9.76%	$5.98M*	$16.73M*	(m)	$10.47M	$64.22M	$4.47M
2023-06-30	Reported	$11.97M	(m)	(m)	(m)	10.21%	$7.50M*	$8.65M*	(m)	$10.94M	$70.32M	$3.86M
2023-03-31	Reported	(m)	-$4.00M	(m)	(m)	(m)	$7.56M	-$5.08M	(m)	$11.20M	$73.83M	-$1.66M
2022-09-30	Reported	(m)	$1.78M	(m)	(m)	(m)	$10.40M*	$5.45M*	(m)	$9.57M	$79.33M	$997.00K
2022-06-30	Reported	(m)	$11.94M	(m)	(m)	(m)	$6.17M*	$10.20M*	(m)	$10.21M	$72.61M	$2.44M
2022-03-31	Reported	(m)	-$128.00K	(m)	(m)	(m)	$6.67M	$1.41M	(m)	$8.59M	$63.58M	$45.00K
2021-09-30	Reported	(m)	$16.26M	(m)	(m)	(m)	$16.70M*	$27.85M*	(m)	$8.95M	$62.37M	$303.00K
2021-06-30	Reported	(m)	$23.59M	(m)	(m)	(m)	$4.33M*	$17.48M*	(m)	$7.32M	$62.35M	$487.00K
2021-03-31	Reported	(m)	$12.62M	(m)	(m)	(m)	$4.96M	-$1.30M	(m)	$6.21M	$58.23M	$200.00K
2020-09-30	Reported	(m)	$22.80M	(m)	(m)	(m)	$5.85M*	$8.87M*	(m)	$3.71M	$51.33M	$72.00K
2020-06-30	Reported	(m)	-$2.25M	(m)	(m)	(m)	$2.17M*	-$9.34M*	(m)	$4.67M	$46.50M	$27.00K
2020-03-31	Reported	(m)	-$15.08M	(m)	(m)	(m)	$4.24M	-$17.28M	(m)	$5.41M	$52.61M	$35.00K
2019-09-30	Reported	(m)	-$8.27M	(m)	(m)	(m)	$1.27M*	-$5.45M*	(m)	$3.92M	$49.48M	$48.00K
2019-06-30	Reported	(m)	-$7.32M	(m)	(m)	(m)	$934.00K*	-$12.12M*	(m)	$3.86M	$48.96M	$23.00K
2019-03-31	Reported	(m)	-$12.12M	(m)	(m)	(m)	$317.00K	-$9.56M	(m)	$3.37M	$48.89M	$37.00K
2018-12-31	Reported	(m)	-$4.48M	(m)	(m)	(m)	(m)	(m)	(m)	$3.09M	$47.48M	$2.00K
2018-09-30	Reported	(m)	-$10.07M	(m)	(m)	(m)	$938.00K*	-$22.99M*	(m)	$2.78M	$38.58M	$27.00K
2018-06-30	Reported	(m)	-$17.02M	(m)	(m)	(m)	$492.00K*	-$15.78M*	(m)	$2.05M	$37.73M	$27.00K
2018-03-31	Reported	(m)	-$19.98M	(m)	(m)	(m)	$65.00K	-$4.46M	(m)	$2.82M	$38.16M	$28.00K
2017-12-31	Reported	(m)	-$2.40M	(m)	(m)	(m)	(m)	(m)	(m)	$2.73M	$36.39M	-$233.00K
2017-09-30	Reported	(m)	-$2.62M	(m)	(m)	(m)	(m)	-$168.73K*	(m)	$2.33M	$35.66M	$47.00K
2017-06-30	Reported	(m)	$2.50M	(m)	(m)	(m)	(m)	-$199.74K*	(m)	$2.45M	$33.72M	-$156.00K
2017-03-31	Reported	(m)	-$2.97M	(m)	(m)	(m)	(m)	-$126.29K	(m)	$1.55M	$27.95M	-$6.68M
2016-12-31	Reported	(m)	-$1.30M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-09-30	Reported	(m)	-$14.49K	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-06-30	Reported	(m)	-$500.00	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-03-31	Reported	(m)	-$15.55K	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)

EBITDA 12 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2025-12-31	Reported	$59.97M	(m)	(m)	(m)	10.63%	$14.15M	-$10.31M	(m)	$44.54M	$326.24M	$9.94M
2024-12-31	Reported	$12.34M	(m)	(m)	(m)	2.56%	$10.03M	$14.21M	(m)	$50.27M	$294.51M	-$3.67M
2023-12-31	Reported	$22.97M	(m)	(m)	(m)	5.30%	$24.36M	$30.92M	(m)	$44.38M	$269.75M	$5.45M
2022-12-31	Reported	$28.15M	(m)	(m)	(m)	6.24%	$33.90M	$24.86M	(m)	$39.76M	$283.81M	$4.75M
2021-12-31	Reported	(m)	$72.22M	(m)	(m)	(m)	$31.22M	$61.98M	(m)	$30.74M	$250.20M	-$31.12M
2020-12-31	Reported	(m)	$26.70M	(m)	(m)	(m)	$17.68M	$5.47M	(m)	$20.09M	$204.19M	$530.00K
2019-12-31	Reported	(m)	-$29.85M	(m)	(m)	(m)	$5.98M	-$33.53M	(m)	$14.80M	$200.09M	$150.00K
2019-09-30	Rolling	(m)	-$32.19M*	(m)	(m)	(m)	(m)	(m)	(m)	$14.25M*	$194.80M*	$110.00K*
2019-06-30	Rolling	(m)	-$33.99M*	(m)	(m)	(m)	(m)	(m)	(m)	$13.11M*	$183.91M*	$89.00K*
2019-03-31	Rolling	(m)	-$43.70M*	(m)	(m)	(m)	(m)	(m)	(m)	$11.29M*	$172.69M*	$93.00K*
2018-12-31	Reported	(m)	-$51.56M	(m)	(m)	(m)	$1.86M	-$60.63M	(m)	$10.74M	$161.96M	$84.00K
2018-12-31	Rolling	(m)	-$51.56M*	(m)	(m)	(m)	(m)	(m)	(m)	$10.74M*	$161.96M*	$84.00K*
2018-09-30	Rolling	(m)	-$49.48M*	(m)	(m)	(m)	(m)	(m)	(m)	$10.39M*	$150.87M*	-$151.00K*
2018-06-30	Rolling	(m)	-$42.02M*	(m)	(m)	(m)	(m)	(m)	(m)	$9.93M*	$147.95M*	-$131.00K*
2018-03-31	Rolling	(m)	-$22.50M*	(m)	(m)	(m)	(m)	(m)	(m)	$10.34M*	$143.93M*	-$314.00K*
2017-12-31	Reported	(m)	-$5.49M	(m)	(m)	(m)	$2.43M	-$3.49M	(m)	$9.06M	$133.72M	-$7.03M
2017-12-31	Rolling	(m)	-$5.49M*	(m)	(m)	(m)	(m)	(m)	(m)	$9.06M*	$133.72M*	-$7.03M*
2017-09-30	Rolling	(m)	-$4.39M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2017-06-30	Rolling	(m)	-$1.79M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2017-03-31	Rolling	(m)	-$4.28M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-12-31	Reported	(m)	-$8.78M	(m)	(m)	(m)	$1.36M	-$4.87M	(m)	$6.28M	$93.03M	$65.00K
2016-12-31	Rolling	(m)	-$1.33M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
AN2 Therapeutics, Inc. (ANTX)	United States	$0.185B	-4.84
PepGen Inc. (PEPG)	United States	$0.186B	-1.73
ALX ONCOLOGY HOLDINGS INC (ALXO)	United States	$0.187B	-3.52
Fortress Biotech, Inc. (FBIO)	United States	$0.188B	0.91
Zentalis Pharmaceuticals, Inc. (ZNTL)	United States	$0.196B	-2.48
Tonix Pharmaceuticals Holding Corp. (TNXP)	United States	$0.166B	-1.34
Minerva Neurosciences, Inc. (NERV)	United States	$0.165B	-0.66
ORAMED PHARMACEUTICALS INC. (ORMP)		$0.199B	1.13
ADC Therapeutics SA (ADCT)		$0.163B	-1.39
LIFECORE BIOMEDICAL, INC. DE (LFCR)	United States	$0.163B	-8.50